Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 CHF | -0.96% | +0.87% | -5.71% |
25/04 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Sales 2023 | 103M 114M 9.47B | Sales 2024 * | 51.09M 56.18M 4.68B | Capitalization | 105M 115M 9.6B |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 0.87 x |
Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 2.05 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 46 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.76% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 day | -0.96% | ||
1 week | +0.87% | ||
Current month | -0.11% | ||
1 month | -6.09% | ||
3 months | -7.04% | ||
6 months | -3.44% | ||
Current year | -5.71% |
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 01/19/01 |
Thomas Meier
FOU | Founder | 62 | 07/04/07 |
Andrew P. Smith
DFI | Director of Finance/CFO | 61 | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 07/04/07 |
Director/Board Member | 56 | 04/17/04 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 27/23/27 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 9.25 | -0.96% | 16,765 |
16/24/16 | 9.34 | -0.64% | 11,109 |
15/24/15 | 9.4 | +2.17% | 22,300 |
14/24/14 | 9.2 | +0.66% | 5,865 |
13/24/13 | 9.14 | -0.33% | 9,439 |
Delayed Quote Swiss Exchange, May 17, 2024 at 09:00 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.71% | 117M | |
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+51.58% | 4.83B | |
+12.50% | 4.09B | |
-20.70% | 2.35B | |
+12.83% | 2.32B | |
+19.51% | 2.27B | |
-29.65% | 2.19B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- SANN Stock